Copyright Reports & Markets. All rights reserved.

Global Influenza Vaccines Market Research Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Influenza Vaccines Industry
  • 1.7 COVID-19 Impact: Influenza Vaccines Market Trends

    • 2 Global Influenza Vaccines Quarterly Market Size Analysis

    • 2.1 Influenza Vaccines Business Impact Assessment - COVID-19
      • 2.1.1 Global Influenza Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Influenza Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Influenza Vaccines Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Influenza Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Influenza Vaccines Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Influenza Vaccines Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Influenza Vaccines Market
    • 3.5 Key Manufacturers Influenza Vaccines Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Influenza Vaccines Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Trivalent Flu Vaccines
      • 1.4.2 Quadrivalent Flu Vaccines
    • 4.2 By Type, Global Influenza Vaccines Market Size, 2019-2021
      • 4.2.1 By Type, Global Influenza Vaccines Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Influenza Vaccines Price, 2020-2021

    5 Impact of Covid-19 on Influenza Vaccines Segments, By Application

    • 5.1 Overview
      • 5.5.1 Adults
      • 5.5.2 Pediatrics
    • 5.2 By Application, Global Influenza Vaccines Market Size, 2019-2021
      • 5.2.1 By Application, Global Influenza Vaccines Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Influenza Vaccines Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 AstraZeneca
      • 7.1.1 AstraZeneca Business Overview
      • 7.1.2 AstraZeneca Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.1.3 AstraZeneca Influenza Vaccines Product Introduction
      • 7.1.4 AstraZeneca Response to COVID-19 and Related Developments
    • 7.2 CSL
      • 7.2.1 CSL Business Overview
      • 7.2.2 CSL Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.2.3 CSL Influenza Vaccines Product Introduction
      • 7.2.4 CSL Response to COVID-19 and Related Developments
    • 7.3 GlaxoSmithKline
      • 7.3.1 GlaxoSmithKline Business Overview
      • 7.3.2 GlaxoSmithKline Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.3.3 GlaxoSmithKline Influenza Vaccines Product Introduction
      • 7.3.4 GlaxoSmithKline Response to COVID-19 and Related Developments
    • 7.4 Sanofi
      • 7.4.1 Sanofi Business Overview
      • 7.4.2 Sanofi Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.4.3 Sanofi Influenza Vaccines Product Introduction
      • 7.4.4 Sanofi Response to COVID-19 and Related Developments
    • 7.5 Altimmune
      • 7.5.1 Altimmune Business Overview
      • 7.5.2 Altimmune Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.5.3 Altimmune Influenza Vaccines Product Introduction
      • 7.5.4 Altimmune Response to COVID-19 and Related Developments
    • 7.6 BionVax
      • 7.6.1 BionVax Business Overview
      • 7.6.2 BionVax Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.6.3 BionVax Influenza Vaccines Product Introduction
      • 7.6.4 BionVax Response to COVID-19 and Related Developments
    • 7.7 FluGen
      • 7.7.1 FluGen Business Overview
      • 7.7.2 FluGen Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.7.3 FluGen Influenza Vaccines Product Introduction
      • 7.7.4 FluGen Response to COVID-19 and Related Developments
    • 7.8 FOLIA BIOTECH
      • 7.8.1 FOLIA BIOTECH Business Overview
      • 7.8.2 FOLIA BIOTECH Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.8.3 FOLIA BIOTECH Influenza Vaccines Product Introduction
      • 7.8.4 FOLIA BIOTECH Response to COVID-19 and Related Developments
    • 7.9 Genentech
      • 7.9.1 Genentech Business Overview
      • 7.9.2 Genentech Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.9.3 Genentech Influenza Vaccines Product Introduction
      • 7.9.4 Genentech Response to COVID-19 and Related Developments
    • 7.10 Green Cross
      • 7.10.1 Green Cross Business Overview
      • 7.10.2 Green Cross Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.10.3 Green Cross Influenza Vaccines Product Introduction
      • 7.10.4 Green Cross Response to COVID-19 and Related Developments
    • 7.11 Medicago
      • 7.11.1 Medicago Business Overview
      • 7.11.2 Medicago Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.11.3 Medicago Influenza Vaccines Product Introduction
      • 7.11.4 Medicago Response to COVID-19 and Related Developments
    • 7.12 Moderna Therapeutics
      • 7.12.1 Moderna Therapeutics Business Overview
      • 7.12.2 Moderna Therapeutics Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.12.3 Moderna Therapeutics Influenza Vaccines Product Introduction
      • 7.12.4 Moderna Therapeutics Response to COVID-19 and Related Developments
    • 7.13 Novavax
      • 7.13.1 Novavax Business Overview
      • 7.13.2 Novavax Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.13.3 Novavax Influenza Vaccines Product Introduction
      • 7.13.4 Novavax Response to COVID-19 and Related Developments
    • 7.14 Shijiazhuang Yiling Pharmaceutical
      • 7.14.1 Shijiazhuang Yiling Pharmaceutical Business Overview
      • 7.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Introduction
      • 7.14.4 Shijiazhuang Yiling Pharmaceutical Response to COVID-19 and Related Developments
    • 7.15 SK Chemicals
      • 7.15.1 SK Chemicals Business Overview
      • 7.15.2 SK Chemicals Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.15.3 SK Chemicals Influenza Vaccines Product Introduction
      • 7.15.4 SK Chemicals Response to COVID-19 and Related Developments
    • 7.16 UNM Pharma
      • 7.16.1 UNM Pharma Business Overview
      • 7.16.2 UNM Pharma Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.16.3 UNM Pharma Influenza Vaccines Product Introduction
      • 7.16.4 UNM Pharma Response to COVID-19 and Related Developments
    • 7.17 Vaccitech
      • 7.17.1 Vaccitech Business Overview
      • 7.17.2 Vaccitech Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.17.3 Vaccitech Influenza Vaccines Product Introduction
      • 7.17.4 Vaccitech Response to COVID-19 and Related Developments
    • 7.18 Vaxart
      • 7.18.1 Vaxart Business Overview
      • 7.18.2 Vaxart Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.18.3 Vaxart Influenza Vaccines Product Introduction
      • 7.18.4 Vaxart Response to COVID-19 and Related Developments
    • 7.19 Vaxine Pty
      • 7.19.1 Vaxine Pty Business Overview
      • 7.19.2 Vaxine Pty Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.19.3 Vaxine Pty Influenza Vaccines Product Introduction
      • 7.19.4 Vaxine Pty Response to COVID-19 and Related Developments
    • 7.20 Visterra
      • 7.20.1 Visterra Business Overview
      • 7.20.2 Visterra Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.20.3 Visterra Influenza Vaccines Product Introduction
      • 7.20.4 Visterra Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Influenza Vaccines Supply Chain Analysis
      • 8.1.1 Influenza Vaccines Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Influenza Vaccines Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Influenza Vaccines Distribution Channels
      • 8.2.2 Covid-19 Impact on Influenza Vaccines Distribution Channels
      • 8.2.3 Influenza Vaccines Distributors
    • 8.3 Influenza Vaccines Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Influenza Vaccines, including the following market information:
      Global Influenza Vaccines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Influenza Vaccines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Influenza Vaccines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Influenza Vaccines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include AstraZeneca, CSL, GlaxoSmithKline, Sanofi, Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, Visterra, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Trivalent Flu Vaccines
      Quadrivalent Flu Vaccines

      Based on the Application:
      Adults
      Pediatrics

      Buy now